Search
Aclarion Inc
ACONAdd to Watchlist
3.001USD
-0.119-3.81%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
2.56MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Aclarion Inc is 8.00, ranking 164 out of 389 in the Biotechnology & Medical Research industry. The average price target is 23.00, with a high of 23.00 and a low of 23.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
7.500
Target Price
+140.38%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Aclarion Inc
ACON
1
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Aclarion Inc's expected revenue for the next quarter?
Aclarion Inc's expected revenue is 30.00K.
What is Aclarion Inc's price target?
Analysts forecast that Aclarion Inc's price target is USD 23.00, with the highest forecast at USD 23.00 and the lowest forecast at USD 23.00.
How have Aclarion IncACON's recent earnings per share performed?
The market expectation was USD -1.34, while Aclarion IncACON's earnings per share (EPS) for the previous quarter was USD -2.54. EPS for the next quarter is expected at USD -0.95.
What is the analyst rating for Aclarion Inc?
Based on the ratings of Aclarion Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
